ALL-MED - Specjalistyczna Opieka Medyczna - Medyczny Instytut Badawczy
- Address
- al. Gen. Józefa Hallera 95, 53-201 Wroclaw, Poland
Otorhinolaryngologic Diseases
The research team at ALL-MED - Specjalistyczna Opieka Medyczna - Medyczny Instytut Badawczy is focusing on innovative treatments for perennial allergic rhinitis. Current studies aim to assess how a targeted antibody can reduce nasal congestion and other persistent symptoms, offering a potential new option for patients who have limited relief from existing therapies.
- Evaluation of nasal symptom relief
- Comparison with placebo outcomes
- Impact on quality of life measures
These investigations contribute to the broader effort to improve management of chronic upper airway inflammation and provide clearer guidance for clinicians treating this condition.
Respiratory Tract Diseases
In the respiratory domain, investigators are examining the long‑term safety of Depemokimab (GSK3511294) for individuals with severe asthma featuring an eosinophilic phenotype. The open‑label extension study monitors participants over a year to ensure that the biologic remains well‑tolerated while delivering sustained disease control alongside standard asthma therapy.
- Long‑term safety monitoring
- Assessment of eosinophil‑driven inflammation
- Integration with existing asthma treatments
Findings from this work aim to expand therapeutic options for patients whose asthma is difficult to manage, potentially reducing exacerbations and improving overall respiratory health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ALL-MED - Specjalistyczna Opieka Medyczna - Medyczny Instytut Badawczy
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Lebrikizumab and Mometasone Furoate in Adult Patients with Perennial Allergic Rhinitis: A Phase 3 Randomized Controlled Trial | Eli Lilly & Co. | Phase III | Not Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Depemokimab | 1 | Unknown | 2021-07-26 | 2021-07-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.